Wouter Korver

Title: Wouter Korver: Innovator in Antibody Research

Introduction

Wouter Korver is a prominent inventor based in Menlo Park, California, known for his significant contributions to the field of antibody research. With a total of seven patents to his name, Korver has made strides in developing innovative solutions for treating various diseases.

Latest Patents

Among his latest patents, Korver has developed antibodies to NTB-A, which include anti-NTB-A antibodies and antigen-binding fragments. These innovations are crucial for creating pharmaceutical compositions that can effectively bind to NTB-A and treat diseases, particularly hematologic malignancies characterized by the expression of NTB-A. Additionally, he has patented methods for monitoring human anti-human antibody responses and inhibitors thereof. These methods focus on identifying and creating human or humanized antibodies that minimize the risk of inducing a Human Anti-Human Antibody (HAHA) response when administered to human hosts. His work also includes predicting the likelihood of a HAHA response and screening for anti-HAHA compounds.

Career Highlights

Wouter Korver has worked with notable companies in the biotechnology sector, including Arca Biopharma, Inc. and Amgen Fremont Inc. His experience in these organizations has allowed him to refine his expertise in antibody development and therapeutic applications.

Collaborations

Throughout his career, Korver has collaborated with esteemed colleagues, including Arie Abo and Larry L. Green. These partnerships have contributed to the advancement of his research and the successful development of his patented technologies.

Conclusion

Wouter Korver's innovative work in antibody research has led to significant advancements in the treatment of diseases, showcasing his dedication to improving healthcare through scientific innovation. His contributions continue to impact the field positively.